Skip to main content

Desai Veeral's Form 4 filing

agilon health, inc. (AGL) · filed Sep 15, 2021

Accession no.
0001209191-21-056200
Filed
Sep 15, 2021
Trade date
Sep 14, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.51M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Desai VeeralCIK 0001855973Officer (Chief Strategy & Dev. Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 14, 2021Common StockMOption exerciseAcquired+121,001$1.00+$121,001382,957Direct
Sep 14, 2021Common StockSSaleDisposed−121,001$28.98−$3,506,608.98261,956Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 14, 2021Common StockMOption exerciseDisposed−121,001$0.00$01,078,999Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)